Evidence map›Paper›PMID 35510349›Full record

ArticleTurkish journal of pharmaceutical sciences2022

Simple and Sensitive RP-HPLC and UV Spectroscopic Methods for the Determination of Remogliflozin Etabonate in Pure and Pharmaceutical Formulations

Nandeesha Itigimatha, Kailash S Chadchan, Basappa C Yallur, Manjunatha D Hadagali

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nandeesha ItigimathaVisvesvaraya Technological University, Ramaiah Institute of Technology, Department of Chemistry, Bangalore, IndiaORCID 0000-0002-7220-6003
Kailash S ChadchanBLDEA's V.P. Dr. P.G. Halakatti College of Engineering and Technology, Department of Chemistry, Karnataka, IndiaORCID 0000-0002-5439-9438
Basappa C YallurVisvesvaraya Technological University, Ramaiah Institute of Technology, Department of Chemistry, Bangalore, IndiaORCID 0000-0002-9099-7056
Manjunatha D HadagaliDavangere University, Department of Studies in Chemistry, Karnataka, IndiaORCID 0000-0002-0634-6198

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Simple, novel and selective reverse phase-high performance liquid chromatography (RP-HPLC) and ultraviolet (UV) spectroscopic methods have been developed and optimized for the determination of remogliflozin etabonate (RMZ) in bulk and dosage forms. In the HPLC method, the principal peak and internal standard peak were eluted separately at different retention times (RT) with the chromatographic conditions such as, mobile phase consisting of 0.02 M ammonium acetate buffer (pH was adjusted to 4.0 by 1.0 M ortho phosphoric acid), acetonitrile and tetrahydrofuran in the ratio 50:45:05, respectively (v/v) and the stationary phase used was C18, 5 μm, 4.6 mm x 250 mm kromasil column. The flow rate was 2.0 mL min

Indexed as

bulk and dosage formsRemogliflozin etabonateRP-HPLCUV spectroscopy

Identifiers

PMID35510349
PMCPMC9083516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.